DNAPrint Genomics, Inc.
DNAG
$0.00
$0.000.00%
OTC PK
| 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | 09/30/2006 | |
|---|---|---|---|---|---|
| Net Income | 63.65% | 43.31% | 36.77% | -41.68% | -122.35% |
| Total Depreciation and Amortization | 12.94% | 30.38% | 53.16% | 140.79% | 148.28% |
| Total Amortization of Deferred Charges | -72.85% | -61.51% | -50.21% | -28.41% | 146.56% |
| Total Other Non-Cash Items | -132.56% | -137.73% | -124.63% | -13.32% | 152.47% |
| Change in Net Operating Assets | -31.66% | 805.16% | 174.96% | 301.40% | 1,639.67% |
| Cash from Operations | 35.51% | 35.98% | 1.65% | -60.35% | -73.20% |
| Capital Expenditure | 38.87% | -31.97% | -32.20% | -216.75% | -177.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,796.69% | 1,887.48% | 220.90% | 126.76% | 108.20% |
| Cash from Investing | 8,541.19% | 1,062.63% | 196.34% | 107.43% | 97.37% |
| Total Debt Issued | -91.79% | -89.68% | -29.75% | 14.94% | 210.09% |
| Total Debt Repaid | 24.99% | 25.87% | 15.44% | -85.67% | -551.31% |
| Issuance of Common Stock | -74.68% | -73.79% | -68.32% | -32.03% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 71.43% |
| Cash from Financing | -124.03% | -114.26% | -67.66% | -33.56% | 15.13% |
| Foreign Exchange rate Adjustments | -27.71% | 254.22% | 323.53% | 1,500.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.81% | -197.06% | -994.97% | -246.34% | 79.25% |